Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer-Reference-Cited by-同舟云学术

Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer

Published:2021-05 Issue:13 Volume:127 Page:2279-2293
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Garcia‐Soto Arlene E.¹^ORCID,McKenzie Nathalie D.¹^ORCID,Whicker Margaret E.²^ORCID,Pearson Joseph M.¹^ORCID,Jimenez Edward A.¹,Portelance Lorraine¹^ORCID,Hu Jennifer J.¹,Lucci Joseph A.³,Qureshi Rehman⁴,Kossenkov Andrew⁴^ORCID,Schwartz Lauren⁵,Mills Gordon B.⁶^ORCID,Maity Amit⁷^ORCID,Lin Lilie L.⁸^ORCID,Simpkins Fiona²^ORCID

Affiliation:

1. Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Miami Florida

2. Division of Gynecology Oncology Department of Obstetrics and Gynecology University of Pennsylvania School of Medicine Philadelphia Pennsylvania

3. The University of Texas Health Science Center at Houston Houston Texas

4. The Wistar Institute Philadelphia Pennsylvania

5. Department of Pathology University of Pennsylvania School of Medicine Philadelphia Pennsylvania

6. The Knight Cancer InstituteOregon Health Sciences University Portland Oregon

7. Department of Radiation Oncology University of Pennsylvania School of Medicine Philadelphia Pennsylvania

8. The University of Texas MD Anderson Cancer CenterThe University of Texas Health Science Center at Houston Houston Texas

Funder

Foundation for the National Institutes of Health

Abramson Family Cancer Research Institute

American Society of Clinical Oncology

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33449

Reference37 articles.

1. Survival and prognosis of women with invasive cervical cancer according to age

2. International Agency for Research on Cancer World Health Organization.Cancer Today. Age standardized (World) incidence rates cervix uteri all ages. Accessed September 1 2020.https://gco.iarc.fr/today/data/factsheets/cancers/23‐Cervix‐uteri‐fact‐sheet.pdf

3. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis

4. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

5. Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of the Protease Inhibitor, Saquinavir, to Treat Anal Cancer Spheroids Derived From Human Papillomavirus Transgenic Mice;Diseases of the Colon & Rectum;2023-01-04

2. Cancer trials as opportunities to serve and learn from individuals with human immunodeficiency virus;Cancer;2022-12-28

3. Drug repurposing as a potential source of innovative therapies in cervical cancer;International Journal of Gynecologic Cancer;2022-09-22

4. Outcomes of Cervical Cancer in HIV-Positive Women Treated With Radiotherapy at a Tertiary Care Center in India;JCO Global Oncology;2022-05

5. Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial;BMJ Open;2022-04